Delivery Order SPE2DR25D2014-SPE2DR26FZ89A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens in 0.5 ml doses, with a ceiling value of $13,305.28 and a firm fixed price structure. This non-competitive delivery order is scheduled for completion by December 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on June 2, 2025, with a ceiling value of $1,501.50 and an ultimate completion date of June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,790.18 on December 4, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,488.88 on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This firm fixed-price contract, with a completion date of October 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order was awarded non-competitively as a competitively...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens valued at $4,911.97 on August 25, 2025. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor vehicle extending through December 2026. The delivery order is set to be completed...
- The Defense Logistics Agency awarded a $21,707.66 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 3 mg/0.5 ml pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,933.25 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a completion date of October 24, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location, serving as a critical node in the federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,162.96 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical supply transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. The award is not designated as a set-aside contract and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,300.52 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal medical procurement requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens in 0.5 ml quantities, with a ceiling value of $1,381.59. This competitively awarded, firm fixed-price delivery order is set to be completed by July 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-unit pharmaceutical procurement supporting military and...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ89ADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trulicity 3 mg/0.5 ml pens valued at $3,488.88 with a completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. AmerisourceBergen's strong competitive position reflects its capability to meet federal procurement requirements and its role as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 12/4/25 |